From years of experience in market access and the pharmaceutical industry, to our trusted client partnerships, we share our insights into what we believe has led to the team’s success and growth over the years.
Valid Insight’s Senior Executive Advisor, Raf De Wilde, has over 40 years’ experience in the pharmaceutical industry and over 30 years’ experience in global market access. Watch our video as he shares his expert insights in pharmaceutical pricing and market access:
Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.
In October 2019, Valid Insight received the Queen’s Award for Enterprise in International Trade – recognised globally as one of the highest accolades for business success. Our video captures the best moments from the award ceremony. Watch it here:
In April this year, Valid Insight were awarded the Queen’s Award for Enterprise in International Trade 2019 – the UK’s most esteemed business award, given only to those companies who have demonstrated outstanding results in their field and achieved significant growth and success over three years. Winning this award is invaluable to our team and […]
In April, it was announced that the Valid Insight team had been awarded the Queen’s Award for Enterprise in International Trade. It was an amazing moment for us all. It was not only a testament to the team’s hard work and indisputable expertise, but to our clients’ trust in us to help them to keep […]
As part of our corporate responsibility to bring new talent in to the industry, our Senior Executive Advisor, Raf De Wilde, will be returning to the University of Duisburg-Essen to deliver a one-day masterclass on patient-reported outcomes and real-world evidence for students studying a Master of Science (MSc) in Pharmaceutical Medicine. We look forward to […]
The second edition of the medical writing in HEOR/Market Access careers guide was launched in June 2019. This guide focuses on medical writing roles in the HEOR/market access arenas, but will be of interest to anyone who wants to understand more about the business of ensuring access to new medicines and devices for patients. If you have […]
The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field. Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s […]
Leukaemia is the 12th most common cancer in Europe, and the 11th most common worldwide. Leuka is a specialist leukaemia charity, investing in the next generation of leukaemia research talent in the UK and beyond. In 2017, Leuka raised nearly £1 million for research, and awarded £2.2 million to blood cancer specialist researchers and £1 […]